Stay updated on Teplizumab in Recent-Onset Type 1 Diabetes Clinical Trial
Sign up to get notified when there's something new on the Teplizumab in Recent-Onset Type 1 Diabetes Clinical Trial page.

Latest updates to the Teplizumab in Recent-Onset Type 1 Diabetes Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedPage revision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check25 days agoChange DetectedThe page now shows Revision: v3.4.3 and no longer shows Revision: v3.4.2.SummaryDifference0.0%

- Check54 days agoChange DetectedAdded Revision: v3.4.2 and removed the older Notice about government funding lapses and operating status (Revision: v3.4.1).SummaryDifference0.3%

- Check61 days agoChange DetectedAdded a funding-status notice about potential data-outdatedness due to a government funding lapse and updated the page revision from v3.4.0 to v3.4.1.SummaryDifference0.3%

- Check68 days agoChange DetectedNew UI/text additions include a 'Show glossary' option, a 'Last Update Submitted that Met QC Criteria' label (replacing the previous 'Last Update Submitted that met QC Criteria'), and capitalization tweaks for the No FEAR Act notice, along with a Revision badge showing v3.4.0 instead of v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check82 days agoChange DetectedRevision: v3.3.4 was added and Revision: v3.3.3 was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Teplizumab in Recent-Onset Type 1 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Teplizumab in Recent-Onset Type 1 Diabetes Clinical Trial page.